Valuation Vista Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 05:02:26 2026-11-02 EST			5-day change	1st Jan Change
6.310 ^INR	+1.61%		+10.51%	-22.48%

09-12	Vista Pharmaceuticals Limited Announces Resignation of Barkha Jain from Company Secretary and Compliance Officer, Effective September 4, 2026	CI
08-14	Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	160.9	403.6	339.2	311.9	705.8	825.3
Change	-	150.81%	-15.96%	-8.06%	126.29%	16.93%
Enterprise Value (EV) ¹	313.4	552	464	409.5	784.5	892
Change	-	76.16%	-15.94%	-11.76%	91.6%	13.7%
P/E	-4.34x	-16.6x	-40.8x	-5.44x	-10.3x	-13.6x
PBR	0.54x	1.01x	0.96x	0.86x	1.24x	1.46x
PEG	-	0.3x	0.7x	-0x	0.3x	0.6x
Capitalization / Revenue	0.71x	31.9x	86x	31.1x	6.86x	8.19x
EV / Revenue	1.38x	43.6x	118x	40.8x	7.63x	8.85x
EV / EBITDA	-7.01x	-31.9x	-38.3x	-10.5x	-24.6x	-22.9x
EV / EBIT	-5.39x	-22.5x	-25.4x	-9.1x	-20.1x	-19.3x
EV / FCF	-10.4x	69.9x	-46.9x	-16x	-27.2x	-14.6x
FCF Yield	-9.66%	1.43%	-2.13%	-6.23%	-3.67%	-6.85%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-1.22	-0.5441	-0.2261	-1.537	-1.033	-0.7906
Distribution rate	-	-	-	-	-	-
Net sales ¹	227.6	12.66	3.945	10.04	102.9	100.7
EBITDA ¹	-44.72	-17.3	-12.11	-38.84	-31.86	-38.93
EBIT ¹	-58.19	-24.57	-18.27	-45.01	-39.05	-46.31
Net income ¹	-36.77	-18.85	-8.319	-56.62	-45.12	-46.49
Net Debt ¹	152.4	148.4	124.8	97.55	78.7	66.71
Reference price ²	5.300	9.040	9.220	8.360	10.660	10.740
Nbr of stocks (in thousands)	30,365	44,651	36,794	37,309	66,211	76,842
Announcement Date	12/7/20	9/1/21	9/7/22	9/7/23	9/8/24	9/8/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VISTA PHARMACEUTICALS LIMITED	-	-	-	-	4.03M
ELI LILLY AND COMPANY	41.42x	14.01x	31.06x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	36.71x	8.6x	17.71x	2.35%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	97.38x	6.07x	25.8x	2.28%	369B
NOVARTIS AG	23.19x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.47x	4.89x	13.87x	1.77%	290B
AMGEN INC.	29.55x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-40.86x	7.45x	46.76x	1.94%	212B
Average	30.40x	7.39x	21.67x	2.01%	426.19B
Weighted average by Cap.	36.41x	8.82x	22.82x	1.69%